Indoco Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
252.10
0.2 (0.08%)
BSENSE

Dec 05

BSE+NSE Vol: 5.44 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,664.92
1,817.29
1,668.61
1,540.75
1,241.53
1,106.59
968.45
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,664.92
1,817.29
1,668.61
1,540.75
1,241.53
1,106.59
968.45
Raw Material Cost
396.27
485.01
412.02
393.66
303.20
262.68
240.17
Purchase of Finished goods
140.93
115.66
102.72
89.43
63.04
75.80
66.76
(Increase) / Decrease In Stocks
-39.02
-41.48
6.55
-26.30
-12.13
-8.05
13.32
Employee Cost
394.05
361.93
322.58
293.70
274.02
256.51
231.66
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
76.01
97.16
80.97
74.64
59.70
49.70
51.51
Other Expenses
597.42
554.70
457.67
388.28
329.43
346.74
288.37
Total Expenditure (Excl Depreciation)
1,565.66
1,572.98
1,382.51
1,213.41
1,017.26
983.38
891.79
Operating Profit (PBDIT) excl Other Income
99.26
244.31
286.10
327.34
224.27
123.21
76.66
Other Income
5.45
9.85
2.34
2.33
3.12
2.44
6.14
Operating Profit (PBDIT)
104.71
254.16
288.44
329.67
227.39
125.65
82.80
Interest
66.23
38.02
25.03
14.14
22.26
26.25
20.54
Exceptional Items
0.99
11.53
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
39.47
227.67
263.41
315.53
205.13
99.40
62.26
Depreciation
113.84
91.87
70.61
78.96
73.13
70.82
71.57
Profit Before Tax
-74.37
135.80
192.80
236.57
132.00
28.58
-9.31
Tax
3.58
38.79
50.55
81.77
38.95
4.46
-6.41
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-77.95
97.01
142.25
154.80
93.05
24.12
-2.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-77.95
97.01
142.25
154.80
93.05
24.12
-2.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.21
1.46
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-73.74
98.47
142.25
154.80
93.05
24.12
-2.90
Equity Capital
18.45
18.44
18.43
18.43
18.43
18.43
18.43
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
1,003.55
1,091.46
1,009.82
886.21
750.56
661.14
642.19
Earnings per share (EPS)
-7.99
10.68
15.44
16.8
10.1
2.62
-0.31
Diluted Earnings per share
-8.45
10.51
15.44
16.8
10.1
2.62
-0.32
Operating Profit Margin (Excl OI)
6.05%
13.66%
17.44%
21.77%
18.4%
11.41%
8.14%
Gross Profit Margin
2.4%
12.73%
16.06%
20.98%
16.83%
9.2%
6.61%
PAT Margin
-4.75%
5.42%
8.67%
10.29%
7.64%
2.23%
-0.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -8.38% vs 8.91% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is -174.89% vs -30.78% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -59.37% vs -14.61% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 74.20% vs 51.90% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Indoco Remedies With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,664.92
2,079.21
-414.29
-19.93%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,664.92
2,079.21
-414.29
-19.93%
Raw Material Cost
396.27
1,358.34
-962.07
-70.83%
Purchase of Finished goods
140.93
0.00
140.93
(Increase) / Decrease In Stocks
-39.02
33.51
-72.53
-216.44%
Employee Cost
394.05
216.57
177.48
81.95%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
76.01
0.00
76.01
Other Expenses
597.42
268.49
328.93
122.51%
Total Expenditure (Excl Depreciation)
1,565.66
1,876.91
-311.25
-16.58%
Operating Profit (PBDIT) excl Other Income
99.26
202.30
-103.04
-50.93%
Other Income
5.45
22.41
-16.96
-75.68%
Operating Profit (PBDIT)
104.71
224.71
-120.00
-53.40%
Interest
66.23
14.76
51.47
348.71%
Exceptional Items
0.99
0.00
0.99
Gross Profit (PBDT)
39.47
209.95
-170.48
-81.20%
Depreciation
113.84
71.99
41.85
58.13%
Profit Before Tax
-74.37
137.96
-212.33
-153.91%
Tax
3.58
36.89
-33.31
-90.30%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-77.95
101.07
-179.02
-177.12%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-77.95
101.07
-179.02
-177.12%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
4.21
0.00
4.21
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-73.74
101.07
-174.81
-172.96%
Equity Capital
18.45
58.71
-40.26
-68.57%
Face Value
2.00
2.00
0.00
Reserves
1,003.55
1,628.95
-625.40
-38.39%
Earnings per share (EPS)
-7.99
3.44
-11.43
-332.27%
Diluted Earnings per share
-8.45
3.44
-11.89
-345.64%
Operating Profit Margin (Excl OI)
6.05%
9.73%
0.00
-3.68%
Gross Profit Margin
2.40%
10.10%
0.00
-7.70%
PAT Margin
-4.75%
4.86%
0.00
-9.61%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,664.92 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -8.38% vs 8.91% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit -73.74 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -174.89% vs -30.78% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 99.26 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -59.37% vs -14.61% in Mar 2024

Annual - Interest
Interest 66.23 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 74.20% vs 51.90% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.05%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024